RA患者英夫利昔单抗治疗反应预测数据集
包含32个临床变量,用于预测RA患者对英夫利昔单抗治疗反应(良好/中等)的数据集。

基本信息
资源简介
RA患者英夫利昔单抗治疗反应预测数据集
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 4 个文件、合计 3.77 MB,主题涵盖 Clinical data、Infliximab、Machine-learning、Rheumatoid arthritis、The prediction of clinical response,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《A novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab》。配套论文《A novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab》发表于 Modern Rheumatology(2016),DOI:10.3109/14397595.2016.1168536。源站首次发布:2016-10-26。
【数据内容】
源站原始描述:Objectives: The aim of the present study was to generate a novel method for predicting the clinical response to infliximab (IFX), using a machine-learning algorithm with only clinical data obtained before the treatment in rheumatoid arthritis (RA) patients. Methods: We obtained 32 variables out of the clinical data on the patients from two independent hospitals. Next, we selected both clinical parameters and machine-learning algorithms and decided the candidates of prediction method. These candi…
中文译文(机器翻译,仅供快速理解,请以原文为准):目的:本研究旨在生成一种新方法,用于预测类风湿关节炎(RA)患者对英夫利西单抗(IFX)的临床应答;该方法仅使用治疗前获得的临床数据,并采用机器学习算法。 方法:我们从
【数据结构与技术规格】
文件数 4 个,合计 3.77 MB。imor_a_1168536_sm0953.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,2.46 MB。imor_a_1168536_sm0952.pdf:application/pdf,1.29 MB。imor_a_1168536_sm0950.csv:text/plain,15.60 KB。数据集 DOI:10.6084/m9.figshare.3249346.v2。
【主题与分类】
源站学科分类:Medicine、Genetics、Pharmacology、Biotechnology、Immunology、Biological Sciences not elsewhere classified。主题标签:Clinical data、Infliximab、Machine-learning、Rheumatoid arthritis、The prediction of clinical response。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://tandf.figshare.com/articles/dataset/A_novel_method_predicting_clinical_response_using_only_background_clinical_data_in_RA_patients_before_treatment_with_infliximab/3249346
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:A novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab. Taylor & Francis. Miyoshi, Fumihiko; Honne, Kyoko; Minota, Seiji; Okada, Masato; Ogawa, Noriyoshi; Mimura, Toshihide
【使用注意】
· 源站最后修改于 2023-06-02,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:A novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab
- DOI:10.6084/m9.figshare.3249346.v2
- 发布日期:2016-10-26
- 文件数:4 个
- 文件总体积:3.77 MB
- 源站页面:https://tandf.figshare.com/articles/dataset/A_novel_method_predicting_clinical_response_using_only_background_clinical_data_in_RA_patients_before_treatment_with_infliximab/3249346
命令行下载
curl -L -o "imor_a_1168536_sm0953.docx" "https://ndownloader.figshare.com/files/6589782"
curl -L -o "imor_a_1168536_sm0952.pdf" "https://ndownloader.figshare.com/files/6589788"
curl -L -o "imor_a_1168536_sm0950.csv" "https://ndownloader.figshare.com/files/6589794"
curl -L -o "imor_a_1168536_sm0948.csv" "https://ndownloader.figshare.com/files/6589797"
文件清单
imor_a_1168536_sm0953.docx(2.46 MB)imor_a_1168536_sm0952.pdf(1.29 MB)imor_a_1168536_sm0950.csv(15.60 KB)imor_a_1168536_sm0948.csv(15.20 KB)
文件总体积 3.77 MB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Objectives: The aim of the present study was to generate a novel method for predicting the clinical response to infliximab (IFX), using a machine-learning algorithm with only clinical data obtained before the treatment in rheumatoid arthritis (RA) patients.
Methods: We obtained 32 variables out of the clinical data on the patients from two independent hospitals. Next, we selected both clinical parameters and machine-learning algorithms and decided the candidates of prediction method. These candidates were verified by clinical variables on different patients from two other hospitals. Finally, we decided the prediction method to achieve the highest score.
Results: The combination of multilayer perceptron algorithm (neural network) and nine clinical parameters shows the best accuracy performance. This method could predict the good or moderate response to IFX with 92% accuracy. The sensitivity of this method was 96.7%, while the specificity was 75%.
Conclusions: We have developed a novel method for predicting the clinical response using only background clinical data in RA patients before treatment with IFX. Our method for predicting the response to IFX in RA patients may have advantages over the other previous methods in several points including easy usability, cost-effectiveness and accuracy.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.3249346.v2(source: https://tandf.figshare.com/articles/dataset/A_novel_method_predicting_clinical_response_using_only_background_clinical_data_in_RA_patients_before_treatment_with_infliximab/3249346)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




